Comparison of RNAscope and immunohistochemistry for evaluation of the UPK2 status in urothelial carcinoma tissues

• Published in: Diagnostic pathology Vol. 17; no. 1; p. 10
• Main Authors: Lu, Jiangli, Zhao, Ming, Wu, Chenyan, Chu, Chengbiao, Zhang, Chris Zhiyi, Cao, Yun
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 14.01.2022; BioMed Central; BMC
• Subjects: Bladder; Bladder cancer; Cancer; Carcinoma; Comparative analysis; Correlation analysis; Diagnosis; Evaluation; Immunohistochemistry; Liver cancer; Metastases; Metastasis; RNAscope; UPK2; Urothelial Carcinoma; China; Immunohistochemistry; Urothelial Carcinoma; RNAscope; UPK2
• ISSN: 1746-1596; 1746-1596
• DOI: 10.1186/s13000-022-01191-x

UPK2 exhibits excellent specificity for urothelial carcinoma (UC). UPK2 evaluation can be useful in making the correct diagnosis of UC. However, UPK2 detection by immunohistochemistry (IHC) has relatively low sensitivity. This paper aimed to compare the diagnostic sensitivity of RNAscope and IHC for evaluation of the UPK2 status in UC. Tissue blocks from 127 conventional bladder UCs, 45 variant bladder UCs, 24 upper tract UCs and 23 metastatic UCs were selected for this study. IHC and RNAscope were used to detect the UPK2 status in UCs. Then, comparisons of the two methods were undertaken. There was no significant difference between RNAscope and IHC for the evaluation of the UPK2 positivity rate in UC (68.0% vs. 62.6%, P = 0.141). Correlation analysis revealed a moderate positive correlation for detection of UPK2: RNAscope vs. IHC (P < 0.001, R = 0.441). Our results showed a trend toward a higher positive UPK2 rate detected by RNAscope (53.3%) than by IHC (35.6%) in variant bladder UCs. Disappointingly, the P value did not indicate a significant difference (P = 0.057). RNAscope for UPK2 appeared to perform similarly to IHC, with a marginally higher positive rate, suggesting it could be used as an alternative or adjunct to UPK2 IHC.